Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Participants With Untreated and Previously Treated Chronic Lymphocytic Leukemia

ClinicalTrials.gov ID: NCT02612311

Public ClinicalTrials.gov record NCT02612311. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 26, 2026, 11:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase 3, Randomized Study to Assess the Efficacy and Safety of Ublituximab in Combination With TGR-1202 (Umbralisib) Compared to Obinutuzumab in Combination With Chlorambucil in Patients With Chronic Lymphocytic Leukemia (CLL)

Study identification

NCT ID
NCT02612311
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
TG Therapeutics, Inc.
Industry
Enrollment
603 participants

Conditions and interventions

Interventions

  • Obinutuzumab Biological
  • Ublituximab Biological
  • TGR-1202 Drug
  • Chlorambucil Drug

Biological · Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 18, 2015
Primary completion
Feb 21, 2023
Completion
Feb 21, 2023
Last update posted
Dec 12, 2024

2015 – 2023

United States locations

U.S. sites
110
U.S. states
37
U.S. cities
103
Facility City State ZIP Site status
TG Therapeutics Investigational Trial Site Huntsville Alabama 35805
TG Therapeutics Investigational Trial Site Mobile Alabama 36604
TG Therapeutics Investigational Trial Site Chandler Arizona 85224
TG Therapeutics Investigational Trial Site Phoenix Arizona 85016
TG Therapeutics Investigational Trial Site Tucson Arizona 85711
TG Therapeutics Investigational Trial Site Fayetteville Arkansas 72703
TG Therapeutics Investigational Trial Site Concord California 94520
TG Therapeutics Investigational Trial Site Duarte California 91010
TG Therapeutics Investigational Trial Site Greenbrae California 94904
TG Therapeutics Investigational Trial Site Pismo Beach California 93449
TG Therapeutics Investigational Trial Site Pleasanton California 94588
TG Therapeutics Investigational Trial Site San Diego California 92120
TG Therapeutics Investigational Trial Site Santa Barbara California 93105
TG Therapeutics Investigational Trial Site Whittier California 90603
TG Therapeutics Investigational Trial Site Aurora Colorado 80012
TG Therapeutics Investigational Trial Site Denver Colorado 80218
TG Therapeutics Investigational Trial Site Bridgeport Connecticut 06606
TG Therapeutics Investigational Trial Site New Haven Connecticut 06519
TG Therapeutics Investigational Trial Site Stamford Connecticut 06904
TG Therapeutics Investigational Trial Site Newark Delaware 19713
TG Therapeutics Investigational Trial Site Boca Raton Florida 33486
TG Therapeutics Investigational Trial Site Fort Myers Florida 33916
TG Therapeutics Investigational Trial Site Jacksonville Florida 32204
TG Therapeutics Investigational Trial Site Jacksonville Florida 32256
TG Therapeutics Investigational Trial Site Ocala Florida 34471
TG Therapeutics Investigational Trial Site Pensacola Florida 32504
TG Therapeutics Investigational Trial Site St. Petersburg Florida 33705
TG Therapeutics Investigational Trial Site Tallahassee Florida 32308
TG Therapeutics Investigational Trial Site Tampa Florida 33612
TG Therapeutics Investigational Trial Site West Palm Beach Florida 33407
TG Therapeutics Investigational Trial Site Albany Georgia 31701
TG Therapeutics Investigational Trial Site Macon Georgia 31201
TG Therapeutics Investigational Trial Site Chicago Illinois 60612
TG Therapeutics Investigational Trial Site Decatur Illinois 62526
TG Therapeutics Investigational Trial Site Maywood Illinois 60153
TG Therapeutics Investigational Trial Site Niles Illinois 60714
TG Therapeutics Investigational Trial Site Peoria Illinois 61615
TG Therapeutics Investigational Trial Site Swansea Illinois
TG Therapeutics Investigational Trial Site Urbana Illinois 61801
TG Therapeutics Investigational Trial Site Fort Wayne Indiana 46804
TG Therapeutics Investigational Trial Site Indianapolis Indiana 46237
TG Therapeutics Investigational Trial Site Ames Iowa 50010
TG Therapeutics Investigational Trial Site Cedar Rapids Iowa 52403
TG Therapeutics Investigational Trial Site Kansas City Kansas 64132
TG Therapeutics Investigational Trial Site Westwood Kansas 66210
TG Therapeutics Investigational Trial Site Louisville Kentucky 40207
TG Therapeutics Investigational Trial Site Baltimore Maryland 21202
TG Therapeutics Investigational Trial Site Baltimore Maryland 21215
TG Therapeutics Investigational Trial Site Bethesda Maryland 20817
TG Therapeutics Investigational Trial Site Columbia Maryland 21044
TG Therapeutics Investigational Trial Site Boston Massachusetts 02111
TG Therapeutics Investigational Trial Site Worcester Massachusetts 01608
TG Therapeutics Investigational Trial Site Ann Arbor Michigan 48106
TG Therapeutics Investigational Trial Site Detroit Michigan 48202
TG Therapeutics Investigational Trial Site Jackson Michigan 49201
TG Therapeutics Investigational Trial Site Saint Louis Park Minnesota 55416
TG Therapeutics Investigational Trial Site Columbia Missouri 65212
TG Therapeutics Investigational Trial Site Kansas City Missouri
TG Therapeutics Investigational Trial Site Lincoln Nebraska 68510
TG Therapeutics Investigational Trial Site Las Vegas Nevada 89119
TG Therapeutics Investigational Trial Site Lebanon New Hampshire 03756
TG Therapeutics Investigational Trial Site Morristown New Jersey 07962
TG Therapeutics Investigational Trial Site Somerville New Jersey 00876
TG Therapeutics Investigational Trial Site East Setauket New York 11733
TG Therapeutics Investigational Trial Site Glens Falls New York 12801
TG Therapeutics Investigational Trial Site Syracuse New York 13210
TG Therapeutics Investigational Trial Site Charlotte North Carolina 28204
TG Therapeutics Investigational Trial Site Durham North Carolina 27710
TG Therapeutics Investigational Trial Site Durham North Carolina
TG Therapeutics Investigational Trial Site Hickory North Carolina 28602
TG Therapeutics Investigational Trial Site Kinston North Carolina 28501
TG Therapeutics Investigational Trial Site Raleigh North Carolina 27607
TG Therapeutics Investigational Trial Site Washington North Carolina 27889
TG Therapeutics Investigational Trial Site Canton Ohio 44718
TG Therapeutics Investigational Trial Site Cincinnati Ohio 45236
TG Therapeutics Investigational Trial Site Toledo Ohio 43623
TG Therapeutics Investigational Trial Site Portland Oregon 97227
TG Therapeutics Investigational Trial Site Portland Oregon 97239
TG Therapeutics Investigational Trial Site Springfield Oregon 97477
TG Therapeutics Investigational Trial Site Camp Hill Pennsylvania 17011
TG Therapeutics Investigational Trial Site Danville Pennsylvania 17822
TG Therapeutics Investigational Trial Site Hershey Pennsylvania 17033
TG Therapeutics Investigational Trial Site Philadelphia Pennsylvania 19106
TG Therapeutics Investigational Trial Site Pittsburgh Pennsylvania 15224
TG Therapeutics Investigational Trial Site Pittsburgh Pennsylvania 15232
TG Therapeutics Investigational Trial Site Pawtucket Rhode Island 00286
TG Therapeutics Investigational Trial Site Greenville South Carolina 29615
TG Therapeutics Investigational Trial Site Sioux Falls South Dakota 57105
TG Therapeutics Investigational Trial Site Watertown South Dakota 57201
TG Therapeutics Investigational Trial Site Chattanooga Tennessee 37404
TG Therapeutics Investigational Trial Site Nashville Tennessee 37203
TG Therapeutics Investigational Trial Site Austin Texas 78705
TG Therapeutics Investigational Trial Site Bedford Texas 76022
TG Therapeutics Investigational Trial Site Fort Worth Texas 76104
TG Therapeutics Investigational Trial Site Houston Texas 77030
TG Therapeutics Investigational Trial Site San Antonio Texas 78217
TG Therapeutics Investigational Trial Site San Antonio Texas 78229
TG Therapeutics Investigational Trial Site Tyler Texas 75702
TG Therapeutics Investigational Trial Site Ogden Utah 84405
TG Therapeutics Investigational Trial Site Blacksburg Virginia 24060
TG Therapeutics Investigational Trial Site Charlottesville Virginia 22908
TG Therapeutics Investigational Trial Site Fort Belvoir Virginia 22060
TG Therapeutics Investigational Trial Site Olympia Washington 98502
TG Therapeutics Investigational Trial Site Seattle Washington 98104
TG Therapeutics Investigational Trial Site Seattle Washington 98109
TG Therapeutics Investigational Trial Site Spokane Washington 99216
TG Therapeutics Investigational Trial Site Vancouver Washington 98684
TG Therapeutics Investigational Trial Site Yakima Washington 98902
TG Therapeutics Investigational Trial Site Milwaukee Wisconsin 53226
TG Therapeutics Investigational Trial Site Wauwatosa Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 44 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02612311, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 12, 2024 · Synced Jun 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02612311 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →